+5 | The top 5 medtech stories for October 20, 2017

This article was originally published here


Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.

Get this in your inbox everyday by subscribing to our newsletters.

5. This surgical glue seals wounds in 60 seconds news

A potentially life-saving surgical glue that is highly elastic and adhesive can quickly seal wounds in seconds without the need for common staples or sutures.

The surgical glue, called MeTro, is a development from biomedical engineers at the University of Sydney and biomedical engineers from Harvard University. Read more

4. FTC seeks more information on Fresenius’ $2B NxStage buy news

Fresenius Medical Care and NxStage Medical shave received a request from the US Federal Trade Commission asking for more information on Fresenius’ $2 billion acquisition of NxStage, according to an SEC filing.

The companies originally announced the acquisition in August, with Fresenius looking to pay $30 per share for Lawrence, Mass.-based home hemodialysis developer NxStage. Read more

3. Meet the two former Johns Hopkins residents disrupting the wound care market news

Ned Swanson and Denver Lough were plastic surgery residents at Johns Hopkins when they made a choice that would change the course of their lives – they decided to drop out and start a business.

Lough had a technology that they thought could help patients if it ever made it to the market, but their intensely busy schedules at Hopkins didn’t allow for a side project to grow into something bigger. Read more

2. Intuitive Surgical shares rise on Street-topping Q3 earnings news

Shares in Intuitive Surgical rose today after the robotic surgical platform maker handily topped expectations on Wall Street with its 3rd quarter earnings results.

The Sunnyvale, Calif.-based company posted profits of $297.5 million, or $2.55 per share, on sales of $806.1 million for the 3 months ended September 30, for bottom-line growth of 34.3% while sales grew 6.6% compared with the same period during the previous fiscal year. Read more

1. GE Healthcare profits, sales rise despite overall EPS miss news

Shares in GE fell today after the conglomerate met sales expectations but missed on earnings per share by a significant margin, though its healthcare biz saw both sales and profits grow for the 3rd quarter.

GE Healthcare posted profits of $820 million on sales of $4.7 billion for the 3 months ended September 30, clocking gains of 14.4% and 5.4%, respectively, compared to its performance during Q3 2016. Read more

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply